PROSPECTO: INFORMATION FOR THE USER
Ácidos Omega 3 KERN PHARMA 1.000 mg soft capsules EFG
Esters of omega 3 fatty acids at 90%
Read this prospect carefully before starting to take this medication, because
it contains important information for you.
Omega 3 Kern Pharma belongs to a group of medications called “Other cholesterol and triglyceride reducers”.
This medication is indicated for the treatment of high levels of triglycerides (fats present in our body, whose excess is harmful to health) when dietary changes have been insufficient. In certain cases, combination with other medications may be necessary.
Do not take Ácidos Omega 3 Kern Pharma
Warnings and precautions
Consult your doctor or pharmacist:
Children and adolescents
Omega-3 fatty acids should not be administered to children.
Older adults
There is no information on the use of omega-3 fatty acids in patients over 70 years old.
Use of Ácidos Omega 3 Kern Pharma with other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those obtained without a prescription.
If you are taking anticoagulants (blood-thinning medications), such as warfarin, you may need additional blood tests and adjustments to your usual anticoagulant dose.
There is no experience with the combination of omega-3 fatty acids with fibrates in the treatment of hypertriglyceridemia.
Pregnancy and lactation
Consult your doctor or pharmacist before using any medication.
There is no information on the use of omega-3 fatty acids in pregnant women or on the elimination of omega-3 fatty acids in breast milk, so omega-3 fatty acids should not be used during pregnancy or lactation unless strictly necessary.
Driving and operating machinery
No effects have been observed on the ability to drive and operate machinery.
Follow these instructions unless your doctor has given you different instructions. In those cases, it is advisable to ask your doctor for written instructions and make sure you understand them well.
Your doctor will tell you the duration of treatment with omega 3 acids. Do not stop treatment before consulting with your doctor.
Do not forget to take your medication.
Omega 3 acids must be administered orally. Take the capsules with water. You can take the capsules during meals to help reduce gastrointestinal side effects.
Hipertrigliceridemia (High Triglyceride Levels in Blood)
The usual dose is 2 capsules per day. If you do not get the desired response, your doctor may increase the dose up to 4 capsules per day.
The long-term lipid-reducing effect (after more than a year) is unknown.
If you take more Ácidos Omega 3 Kern Pharma than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Ácidos Omega 3 Kern Pharma
In case of forgotten dose, take the medication as soon as possible and continue with the treatment as prescribed. However, when the next dose is near, it is better not to take the forgotten dose and wait for the next one. Do not take a double dose to compensate for the forgotten doses.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medications, Ácidos Omega 3 Kern Pharma may produce adverse effects, although not all people will experience them.
The frequencies of adverse effects have been listed below according to the following definitions:
Very frequent (affect more than 1 in 10 patients)
Frequent (affect between 1 and 10 in 100 patients)
Infrequent (affect between 1 and 10 in 1,000 patients)
Rare (affect between 1 and 10 in 10,000 patients)
Very rare (affect fewer than 1 in 10,000 patients)
Frequent: indigestion and nausea, irregular and rapid heart rhythm.
Infrequent: abdominal pain and gastrointestinal disturbances, gastritis, dizziness, alteration of taste, allergic reactions.
Rare: headache, acne, itchy skin rash (hives or urticaria), elevated blood sugar, liver discomfort, gastrointestinal pain, undefined gastrointestinal disturbances.
Very rare: gastrointestinal bleeding, decreased blood pressure, nasal dryness, urticaria, changes in blood, moderate elevation of transaminases (blood tests related to the liver) in patients with elevated triglycerides (hypertriglyceridemia), elevated white blood cell count and LDH.
Other adverse effects have occurred in a very small number of people, but their exact frequency is unknown: itching.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep out of the sight and reach of children.
Do not store above 25 °C. Do not refrigerate or freeze.
Do not use Omega 3 Acids Kern Pharma after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Omega 3 Acids Kern Pharma
Appearance of the product and content of the packaging
Soft gelatin capsule of light yellow color.
Plastic containers with pressure cap containing 100 capsules.
Holder of the marketing authorization
Kern Pharma, S.L.
Venus, 72 – Pol. Ind. Colón II
08228 Terrassa -Barcelona
Spain
Responsible for manufacturing
VIANEX S.A. – Plant A
12km National Road Athens Lamia,
Metamorfossi, 144 51,
Greece
or
ONE PHARMA S.A
60th Km N.N.R Athinon-Lamias
32009 Sximatari, Greece
Last review date of this leaflet: December 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.